OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
May 11, 2022
The agency’s Center for Drug Evaluation and Research has launched the new program to increase development of treatment options for patients with rare diseases.
May 10, 2022
908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.
May 09, 2022
Lonza and Integral Molecular will collaborate to better assess the risks of off-target binding of biologic drug candidates.
MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.
May 06, 2022
FDA is limiting the use of Janssen’s COVID-19 vaccine to certain individuals.
Issues related to mifepristone prescribing and dispensing are emerging in the debate over legislation to reauthorize FDA user fees for drugs and medical products.
May 05, 2022
AstraZeneca has announced plans to open a new strategic R&D center in Cambridge, MA, which will also serve as Alexion’s headquarters.
Janssen has submitted a marketing authorization application to EMA for the approval of a treatment for patients with HRR gene-mutated metastatic castration-resistant prostate cancer.
Purolite has received the Queen’s Award for Enterprise in the International Trade category.
May 04, 2022
Kapruvia has been approved by the European Commission for the treatment of moderate-to-severe pruritis in hemodialysis patients.